Logo image of TNMG

TNL MEDIAGENE (TNMG) Stock Fundamental Analysis

NASDAQ:TNMG - Nasdaq - KYG8924F1054 - Common Stock - Currency: USD

0.91  +0.31 (+52.71%)

Premarket: 0.8485 -0.06 (-6.76%)

Fundamental Rating

1

TNMG gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 96 industry peers in the Media industry. TNMG has a bad profitability rating. Also its financial health evaluation is rather negative. TNMG does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year TNMG has reported negative net income.
In the past year TNMG has reported a negative cash flow from operations.
TNMG Yearly Net Income VS EBIT VS OCF VS FCFTNMG Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 0 5M 10M

1.2 Ratios

The Return On Assets of TNMG (-3.37%) is comparable to the rest of the industry.
TNMG's Return On Equity of -13.77% is in line compared to the rest of the industry. TNMG outperforms 41.67% of its industry peers.
Industry RankSector Rank
ROA -3.37%
ROE -13.77%
ROIC N/A
ROA(3y)4.63%
ROA(5y)N/A
ROE(3y)5.25%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
TNMG Yearly ROA, ROE, ROICTNMG Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 0 2 -2 4 -4 6 8

1.3 Margins

TNMG does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
TNMG Yearly Profit, Operating, Gross MarginsTNMG Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023

More info and screens

1

2. Health

2.1 Basic Checks

The number of shares outstanding for TNMG has been reduced compared to 1 year ago.
The debt/assets ratio for TNMG is higher compared to a year ago.
TNMG Yearly Shares OutstandingTNMG Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 5M 10M 15M 20M
TNMG Yearly Total Debt VS Total AssetsTNMG Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 50M 100M 150M

2.2 Solvency

TNMG has an Altman-Z score of -1.27. This is a bad value and indicates that TNMG is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of -1.27, TNMG is not doing good in the industry: 77.08% of the companies in the same industry are doing better.
A Debt/Equity ratio of 0.51 indicates that TNMG is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.51, TNMG is in the better half of the industry, outperforming 60.42% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.51
Debt/FCF N/A
Altman-Z -1.27
ROIC/WACCN/A
WACCN/A
TNMG Yearly LT Debt VS Equity VS FCFTNMG Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 0 50M 100M 150M

2.3 Liquidity

TNMG has a Current Ratio of 0.01. This is a bad value and indicates that TNMG is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of TNMG (0.01) is worse than 91.67% of its industry peers.
A Quick Ratio of 0.01 indicates that TNMG may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.01, TNMG is doing worse than 91.67% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.01
Quick Ratio 0.01
TNMG Yearly Current Assets VS Current LiabilitesTNMG Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 1M 2M 3M 4M

More info and screens

0

3. Growth

3.1 Past

The earnings per share for TNMG have decreased strongly by -147.00% in the last year.
EPS 1Y (TTM)-147%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-286%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for TNMG. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
TNMG Price Earnings VS Forward Price EarningsTNMG Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
TNMG Per share dataTNMG EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.1 -0.1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for TNMG!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

TNL MEDIAGENE

NASDAQ:TNMG (5/20/2025, 8:00:01 PM)

Premarket: 0.8485 -0.06 (-6.76%)

0.91

+0.31 (+52.71%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryMedia
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.16%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap23.89M
AnalystsN/A
Price TargetN/A
Short Float %0.9%
Short Ratio0.22
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 4.6
P/tB 4.6
EV/EBITDA N/A
EPS(TTM)-0.11
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.05
FCFYN/A
OCF(TTM)-0.05
OCFYN/A
SpS0
BVpS0.2
TBVpS0.2
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -3.37%
ROE -13.77%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)4.63%
ROA(5y)N/A
ROE(3y)5.25%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.51
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.01
Quick Ratio 0.01
Altman-Z -1.27
F-Score2
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-147%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-286%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-8.39%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-34.56%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-34.56%
OCF growth 3YN/A
OCF growth 5YN/A